MedTrace Logo

Development of Airway Absorption Sampling Methods

NCT04494334 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2023-09-15

No results posted yet for this study

Summary

The study will measure airway inflammation in probable idiopathic pulmonary fibrosis (IPF) and sarcoidosis as well as in healthy volunteers. This can help understand the molecular basis of these diseases, why these diseases happen, and what makes patients develop lung fibrosis. These insights should one day help to monitor patients and aid in their diagnosis and treatment.

Conditions

Interventions

PROCEDURE

Bronchoscopy for Probable Idiopathic Pulmonary Fibrosis and Sarcoidosis

Blood samples and Nasosorption sampling

Sponsors & Collaborators

  • Genentech, Inc.

    collaborator INDUSTRY

  • Imperial College London

    lead OTHER

Principal Investigators

  • Melissa Wickremasinghe · Physician

Eligibility

Min Age
40 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-01
Primary Completion
2022-01-01
Completion
2022-01-01

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04494334 on ClinicalTrials.gov